Bristol-Myers Squibb Co (LTS:0R1F)
$ 54.48 -1.095 (-1.97%) Market Cap: 109.81 Bil Enterprise Value: 153.11 Bil PE Ratio: 0 PB Ratio: 6.41 GF Score: 84/100

Bristol-Myers Squibb Co at UBS Global Healthcare Conference (Virtual) Transcript

May 19, 2020 / 03:40PM GMT
Release Date Price: $63.42 (-2.39%)
Navin Cyriac Jacob
UBS Investment Bank, Research Division - Equity Research Analyst of Specialty Pharmaceuticals and Large Cap Pharmaceutic

Hello. Welcome to Day 2 of the UBS Global Healthcare Conference. My name is Navin Jacob. I'm a senior analyst covering large cap pharmaceuticals and some mid-cap biotech.

Our next presentation of fireside chat is with Bristol-Myers Squibb. It's my pleasure to have with me Chris Boerner, Chief Commercial Officer; as well as Samit Hirawat, Chief Medical Officer.

Thank you, both Chris and Samit, for joining us today.

Christopher S. Boerner
Bristol-Myers Squibb Company - Executive VP & Chief Commercialization Officer

It's our pleasure.

Questions & Answers

Navin Cyriac Jacob
UBS Investment Bank, Research Division - Equity Research Analyst of Specialty Pharmaceuticals and Large Cap Pharmaceutic

Perfect. Well, let's -- we can't escape COVID, obviously. So maybe we'll just start off with a few questions there.

Chris, given that Bristol is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot